News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
CPMG Inc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
SC 13D/A
| CPMG Inc reports a 0% stake in Reata Pharmaceuticals, Inc. |
| 08/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/13/2022 |
SC 13D/A
| CPMG Inc reports a 20.7% stake in PROCEPT BioRobotics Corporation |
| 09/08/2022 |
SC 13D/A
| CPMG Inc reports a 23.1% stake in PROCEPT BioRobotics Corporation |
| 10/19/2021 |
SC 13D/A
| CPMG Inc reports a 15% stake in Apollo Endosurgery, Inc. |
| 09/10/2020 |
SC 13D/A
| CPMG Inc reports a 20% stake in Apollo Endosurgery, Inc. |
| 07/22/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/14/2019 |
SC 13D/A
| CPMG Inc reports a 14.2% stake in Apollo Endosurgery, Inc. |
| 07/31/2018 |
SC 13D/A
| CPMG Inc reports a 19.5% stake in Reata Pharmaceuticals, Inc. |
| 12/29/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/13/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/23/2017 |
SC 13D/A
| CPMG Inc reports a 28.4% stake in Reata Pharmaceuticals, Inc. |
| 03/06/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 01/04/2017 |
SC 13D/A
| REATA PHARMACEUTICALS INC reports a 33.7% stake in Reata Pharmaceuticals, Inc. |
| 12/20/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 12/06/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 08/09/2016 |
SC 13D/A
| CPMG Inc reports a 33.2% stake in Reata Pharmaceuticals, Inc. |
| 07/01/2016 |
SC 13D/A
| CPMG Inc reports a 24.5% stake in Reata Pharmaceuticals, Inc. |
| 06/28/2016 |
SC 13D/A
| CPMG Inc reports a 22.7% stake in Reata Pharmaceuticals, Inc. |
| 12/12/2008 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|